Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
SurgePays, Inc. (NASDAQ: SURG)
SURG Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
13.80%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
375.60%
SURG Stock Analysis
SURG
PE Ratio:
SURG
PEG Ratio:
Not Available
SURG
Forward EPS Growth (12 month):
0.00%
SURG
PS Ratio:
0.2
SURG
PSG Ratio:
SURG
Forward Revenue Growth (12 month):
20.00%
SURG Articles
No data was found